Microbot Medical Inc. (MBOT) 10-Year Financial Performance & Capital Metrics

MBOT • • Industrial / General

HealthcareMedical InstrumentsSurgical & Interventional DevicesRobotic Surgery Systems

AboutMicrobot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.Show more

Revenue $0
EBITDA -$12M -18.3%
Net Income -$11M -6.5%
EPS (Diluted) -0.73 +30.5%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -284.97% -56.4%
ROIC -624.78% -216.8%
Debt/Equity 0.03 -38.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Weak momentum: RS Rating 20 (bottom 20%)
✗Shares diluted 53.4% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-16.64%

EPS CAGR

10Y-

5Y-

3Y-

TTM54.47%

ROCE

10Y Avg-116.17%

5Y Avg-131.81%

3Y Avg-190.04%

Latest-286.61%

Peer Comparison

Robotic Surgery Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ISRGIntuitive Surgical, Inc.	203.04B	572.75	89.21	17.24%	28.58%	16.12%	0.64%	0.01
MBOTMicrobot Medical Inc.	143.05M	2.13	-2.92			-16.71%		0.03
STXSStereotaxis, Inc.	238.91M	2.56	-8.53	0.55%	-78.56%	-204.85%		0.53

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	117K	0	0	0	0	0	0	0	0	0
Revenue Growth %	-0.88%	-1%	-	-	-	-	-	-	-	-
Cost of Goods Sold+	17K	10K	21K	54K	84K	0	0	0	106K	91K
COGS % of Revenue	0.15%	-	-	-	-	-	-	-	-	-
Gross Profit+	117K	-10K	-21K	-54K	-84K	0	0	0	-106K	-91K
Gross Margin %	1%	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-0.88%	-1.09%	-1.1%	-1.57%	-0.56%	1%	-	-	-	0.14%
Operating Expenses+	915K	9.63M	5.27M	7.24M	7.16M	9.09M	11.36M	13.28M	9.75M	11.53M
OpEx % of Revenue	7.82%	-	-	-	-	-	-	-	-	-
Selling, General & Admin	9.33M	8.77M	4.2M	4.73M	4.18M	5.89M	5.41M	5.58M	4.13M	5M
SG&A % of Revenue	79.78%	-	-	-	-	-	-	-	-	-
Research & Development	823K	1.11M	1.28M	2.86M	2.97M	3.4M	6.15M	7.74M	5.72M	6.63M
R&D % of Revenue	7.03%	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-230K	-249K	-213K	-476K	0	-195K	-206K	-36K	-106K	-91K
Operating Income+	-36.72M	-9.63M	-5.27M	-7.24M	-7.24M	-9.09M	-11.36M	-13.28M	-9.86M	-11.63M
Operating Margin %	-313.85%	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-0.19%	0.74%	0.45%	-0.38%	0%	-0.26%	-0.25%	-0.17%	0.26%	-0.18%
EBITDA+	-35.59M	-9.63M	-5.25M	-7.19M	-7.16M	-9.02M	-11.28M	-13.18M	-9.75M	-11.53M
EBITDA Margin %	-304.22%	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-0.2%	0.73%	0.45%	-0.37%	0%	-0.26%	-0.25%	-0.17%	0.26%	-0.18%
D&A (Non-Cash Add-back)	1.13M	10K	21K	54K	84K	68K	76K	102K	106K	91K
EBIT	-914K	-9.63M	-5.27M	-7.22M	-7.14M	-9.09M	-11.36M	-13.44M	-10.74M	-11.44M
Net Interest Income+	-499K	0	0	0	-103K	-79.92K	44K	54K	228K	182K
Interest Income	7.54K	0	0	0	0	80	44K	54K	228K	182K
Interest Expense	506.32K	334K	238K	0	103K	80K	0	0	0	0
Other Income/Expense	-6K	-28K	-2.32M	-16K	-7K	-80K	44K	113K	-885K	182K
Pretax Income+	-36.41M	-9.66M	-7.59M	-7.26M	-7.25M	-9.17M	-11.31M	-13.17M	-10.74M	-11.44M
Pretax Margin %	-311.23%	-	-	-	-	-	-	-	-	-
Income Tax+	0	0	0	20K	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-36.41M	-9.66M	-7.59M	-7.26M	-7.25M	-9.17M	-11.31M	-13.17M	-10.74M	-11.44M
Net Margin %	-311.24%	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.11%	0.73%	0.21%	0.04%	0%	-0.27%	-0.23%	-0.16%	0.18%	-0.07%
Net Income (Continuing)	-921K	-9.66M	-7.59M	-7.26M	-7.25M	-9.17M	-11.31M	-13.17M	-10.74M	-11.44M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-7.20	-10.14	-0.85	-0.81	-1.70	-1.29	-1.59	-1.81	-1.05	-0.73
EPS Growth %	0.99%	-0.41%	0.92%	0.05%	-1.1%	0.24%	-0.23%	-0.14%	0.42%	0.3%
EPS (Basic)	-12.58	-10.14	-0.85	-0.81	-1.70	-1.29	-1.59	-1.81	-1.05	-0.73
Diluted Shares Outstanding	73.24K	952.89K	8.92M	8.92M	4.27M	7.12M	7.11M	7.26M	10.2M	15.64M
Basic Shares Outstanding	73.24K	952.89K	8.92M	8.92M	4.27M	7.12M	7.11M	7.26M	10.2M	15.64M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	491K	3.31M	10.93M	5.83M	35.94M	25.25M	15.88M	8.81M	7.92M	5.82M
Cash & Short-Term Investments	437K	2.71M	10.79M	5.24M	31.29M	24.65M	15.49M	8.28M	6.38M	5.47M
Cash Only	12.11M	2.71M	10.79M	5.24M	28.77M	19.65M	13.49M	2.52M	2.47M	3.11M
Short-Term Investments	-11.67M	0	0	0	2.52M	5M	2M	5.76M	3.92M	2.36M
Accounts Receivable	14K	15K	35K	65K	101K	0	174K	103K	1.49M	300K
Days Sales Outstanding	43.68	-	-	-	-	-	-	-	-	-
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	15K	400K	27K	437K	4.36M	424K	87K	3K	49K	49K
Total Non-Current Assets+	6.01M	53K	90K	259K	1.19M	1.03M	888K	723K	406K	212K
Property, Plant & Equipment	5.22M	53K	90K	259K	1.19M	1.03M	888K	723K	406K	212K
Fixed Asset Turnover	0.02x	-	-	-	-	-	-	-	-	-
Goodwill	184	0	0	0	0	0	0	0	0	0
Intangible Assets	45.82K	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	743K	0	0	0	0	0	0	0	0	0
Total Assets+	21.22M	3.37M	11.02M	6.09M	37.13M	26.28M	16.77M	9.54M	8.33M	6.03M
Asset Turnover	0.01x	-	-	-	-	-	-	-	-	-
Asset Growth %	-0.35%	-0.84%	2.27%	-0.45%	5.1%	-0.29%	-0.36%	-0.43%	-0.13%	-0.28%
Total Current Liabilities+	174K	783K	528K	4.76M	4.83M	1.34M	1.98M	2.07M	3.79M	2.46M
Accounts Payable	25K	512K	78K	630K	284K	275K	279K	116K	357K	165K
Days Payables Outstanding	536.76	18.69K	1.36K	4.26K	1.23K	-	-	-	1.23K	661.81
Short-Term Debt	0	0	0	0	0	0	0	283K	0	0
Deferred Revenue (Current)	16.83K	0	0	0	0	0	0	0	0	0
Other Current Liabilities	94.14K	0	386K	3.38M	3.73M	0	0	298K	804K	1.41M
Current Ratio	2.82x	4.23x	20.70x	1.23x	7.45x	18.78x	8.00x	4.26x	2.09x	2.37x
Quick Ratio	2.82x	4.23x	20.70x	1.23x	7.45x	18.78x	8.00x	4.26x	2.09x	2.37x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	419K	889K	528K	0	760K	626K	402K	179K	40K	41K
Long-Term Debt	419K	76K	0	0	0	0	0	0	0	0
Capital Lease Obligations	15.88K	0	0	0	760K	626K	402K	179K	40K	41K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	-15.88K	813K	528K	0	0	0	0	0	0	0
Total Liabilities	21.55M	1.67M	1.06M	4.76M	5.59M	1.97M	2.39M	2.25M	3.83M	2.5M
Total Debt+	454.91K	76K	0	0	903K	813K	680K	462K	231K	111K
Net Debt	-11.66M	-2.63M	-10.79M	-5.24M	-27.87M	-18.84M	-12.81M	-2.06M	-2.24M	-3M
Debt / Equity	-	0.04x	-	-	0.03x	0.03x	0.05x	0.06x	0.05x	0.03x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-72.52x	-28.85x	-22.13x	-	-70.29x	-113.61x	-	-	-	-
Total Equity+	-334K	1.7M	9.96M	1.33M	31.54M	24.31M	14.38M	7.29M	4.5M	3.53M
Equity Growth %	-1.06%	6.08%	4.88%	-0.87%	22.71%	-0.23%	-0.41%	-0.49%	-0.38%	-0.22%
Book Value per Share	-4.56	1.78	1.12	0.15	7.39	3.42	2.02	1.00	0.44	0.23
Total Shareholders' Equity	-334K	1.7M	9.96M	1.33M	31.54M	24.31M	14.38M	7.29M	4.5M	3.53M
Common Stock	1.11B	266K	27K	31K	72K	72K	72K	80K	118K	195K
Retained Earnings	-456.69M	-13.04M	-20.62M	-27.86M	-35.11M	-44.28M	-55.59M	-68.76M	-79.5M	-90.94M
Treasury Stock	0	0	0	-3.38M	-3.38M	0	0	0	0	0
Accumulated OCI	47.36K	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-765K	-786K	-4.86M	-5.31M	-6.45M	-7.25M	-9.35M	-11.55M	-8.53M	-8.83M
Operating CF Margin %	-6.54%	-	-	-	-	-	-	-	-	-
Operating CF Growth %	0.97%	-0.03%	-5.18%	-0.09%	-0.21%	-0.12%	-0.29%	-0.23%	0.26%	-0.03%
Net Income	-921K	-9.66M	-7.59M	-7.26M	-7.25M	-9.17M	-11.31M	-13.17M	-10.74M	-11.44M
Depreciation & Amortization	17K	10K	21K	54K	84K	68K	76K	102K	106K	91K
Stock-Based Compensation	0	676K	479K	1.4M	1.1M	1.94M	1.39M	1.75M	1.39M	1.35M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	7K	7.33M	2.32M	74K	-121K	-70K	0	-7K	718K	234K
Working Capital Changes	132K	862K	-83K	423K	-266K	-18K	497K	-228K	-11K	942K
Change in Receivables	66K	538K	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	292.19K	0	0	0	-140K	0	0	0	0	0
Cash from Investing+	-2K	-25K	-58K	-223K	-2.45M	-2.77M	3.2M	-3.84M	1.97M	1.54M
Capital Expenditures	-2K	-25K	-58K	-223K	-216K	-91K	-69K	-84K	-33K	-25K
CapEx % of Revenue	0.02%	-	-	-	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	259K	-200K	0	-3K	3K	0
Cash from Financing+	413K	3.08M	13.02M	-18K	36.77M	-3.38M	0	4.32M	6.56M	7.94M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-25.93M	2.33M	317K	-18K	0	0	0	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-767K	-811K	-4.91M	-5.53M	-6.67M	-7.34M	-9.42M	-11.63M	-8.57M	-8.85M
FCF Margin %	-6.56%	-	-	-	-	-	-	-	-	-
FCF Growth %	0.97%	-0.06%	-5.06%	-0.13%	-0.2%	-0.1%	-0.28%	-0.23%	0.26%	-0.03%
FCF per Share	-10.47	-0.85	-0.55	-0.62	-1.56	-1.03	-1.33	-1.60	-0.84	-0.57
FCF Conversion (FCF/Net Income)	0.02x	0.08x	0.64x	0.73x	0.89x	0.79x	0.83x	0.88x	0.79x	0.77x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-1315.39%	-1418.94%	-130.17%	-128.56%	-44.09%	-32.84%	-58.48%	-121.53%	-182.19%	-284.97%
Return on Invested Capital (ROIC)	-	-	-	-	-	-149.11%	-242.02%	-292.96%	-197.21%	-624.78%
Gross Margin	100%	-	-	-	-	-	-	-	-	-
Net Margin	-31123.93%	-	-	-	-	-	-	-	-	-
Debt / Equity	-	0.04x	-	-	0.03x	0.03x	0.05x	0.06x	0.05x	0.03x
Interest Coverage	-72.52x	-28.85x	-22.13x	-	-70.29x	-113.61x	-	-	-	-
FCF Conversion	0.02x	0.08x	0.64x	0.73x	0.89x	0.79x	0.83x	0.88x	0.79x	0.77x
Revenue Growth	-88.44%	-100%	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Microbot Medical Inc. (MBOT) grew revenue by 0.0% over the past year. Growth has been modest.

Microbot Medical Inc. (MBOT) reported a net loss of $13.1M for fiscal year 2024.

Dividend & Returns

Microbot Medical Inc. (MBOT) has a return on equity (ROE) of -285.0%. Negative ROE indicates the company is unprofitable.

Microbot Medical Inc. (MBOT) had negative free cash flow of $11.0M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Microbot Medical Inc. (MBOT) 10-Year Financial Performance & Capital Metrics

MBOT • • Industrial / General

HealthcareMedical InstrumentsSurgical & Interventional DevicesRobotic Surgery Systems

Revenue $0
EBITDA -$12M -18.3%
Net Income -$11M -6.5%
EPS (Diluted) -0.73 +30.5%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -284.97% -56.4%
ROIC -624.78% -216.8%
Debt/Equity 0.03 -38.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Weak momentum: RS Rating 20 (bottom 20%)
✗Shares diluted 53.4% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-16.64%

EPS CAGR

10Y-

5Y-

3Y-

TTM54.47%

ROCE

10Y Avg-116.17%

5Y Avg-131.81%

3Y Avg-190.04%

Latest-286.61%

Peer Comparison

Robotic Surgery Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ISRGIntuitive Surgical, Inc.	203.04B	572.75	89.21	17.24%	28.58%	16.12%	0.64%	0.01
MBOTMicrobot Medical Inc.	143.05M	2.13	-2.92			-16.71%		0.03
STXSStereotaxis, Inc.	238.91M	2.56	-8.53	0.55%	-78.56%	-204.85%		0.53

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	117K	0	0	0	0	0	0	0	0	0
Revenue Growth %	-0.88%	-1%	-	-	-	-	-	-	-	-
Cost of Goods Sold+	17K	10K	21K	54K	84K	0	0	0	106K	91K
COGS % of Revenue	0.15%	-	-	-	-	-	-	-	-	-
Gross Profit+	117K	-10K	-21K	-54K	-84K	0	0	0	-106K	-91K
Gross Margin %	1%	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-0.88%	-1.09%	-1.1%	-1.57%	-0.56%	1%	-	-	-	0.14%
Operating Expenses+	915K	9.63M	5.27M	7.24M	7.16M	9.09M	11.36M	13.28M	9.75M	11.53M
OpEx % of Revenue	7.82%	-	-	-	-	-	-	-	-	-
Selling, General & Admin	9.33M	8.77M	4.2M	4.73M	4.18M	5.89M	5.41M	5.58M	4.13M	5M
SG&A % of Revenue	79.78%	-	-	-	-	-	-	-	-	-
Research & Development	823K	1.11M	1.28M	2.86M	2.97M	3.4M	6.15M	7.74M	5.72M	6.63M
R&D % of Revenue	7.03%	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-230K	-249K	-213K	-476K	0	-195K	-206K	-36K	-106K	-91K
Operating Income+	-36.72M	-9.63M	-5.27M	-7.24M	-7.24M	-9.09M	-11.36M	-13.28M	-9.86M	-11.63M
Operating Margin %	-313.85%	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-0.19%	0.74%	0.45%	-0.38%	0%	-0.26%	-0.25%	-0.17%	0.26%	-0.18%
EBITDA+	-35.59M	-9.63M	-5.25M	-7.19M	-7.16M	-9.02M	-11.28M	-13.18M	-9.75M	-11.53M
EBITDA Margin %	-304.22%	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-0.2%	0.73%	0.45%	-0.37%	0%	-0.26%	-0.25%	-0.17%	0.26%	-0.18%
D&A (Non-Cash Add-back)	1.13M	10K	21K	54K	84K	68K	76K	102K	106K	91K
EBIT	-914K	-9.63M	-5.27M	-7.22M	-7.14M	-9.09M	-11.36M	-13.44M	-10.74M	-11.44M
Net Interest Income+	-499K	0	0	0	-103K	-79.92K	44K	54K	228K	182K
Interest Income	7.54K	0	0	0	0	80	44K	54K	228K	182K
Interest Expense	506.32K	334K	238K	0	103K	80K	0	0	0	0
Other Income/Expense	-6K	-28K	-2.32M	-16K	-7K	-80K	44K	113K	-885K	182K
Pretax Income+	-36.41M	-9.66M	-7.59M	-7.26M	-7.25M	-9.17M	-11.31M	-13.17M	-10.74M	-11.44M
Pretax Margin %	-311.23%	-	-	-	-	-	-	-	-	-
Income Tax+	0	0	0	20K	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-36.41M	-9.66M	-7.59M	-7.26M	-7.25M	-9.17M	-11.31M	-13.17M	-10.74M	-11.44M
Net Margin %	-311.24%	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.11%	0.73%	0.21%	0.04%	0%	-0.27%	-0.23%	-0.16%	0.18%	-0.07%
Net Income (Continuing)	-921K	-9.66M	-7.59M	-7.26M	-7.25M	-9.17M	-11.31M	-13.17M	-10.74M	-11.44M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-7.20	-10.14	-0.85	-0.81	-1.70	-1.29	-1.59	-1.81	-1.05	-0.73
EPS Growth %	0.99%	-0.41%	0.92%	0.05%	-1.1%	0.24%	-0.23%	-0.14%	0.42%	0.3%
EPS (Basic)	-12.58	-10.14	-0.85	-0.81	-1.70	-1.29	-1.59	-1.81	-1.05	-0.73
Diluted Shares Outstanding	73.24K	952.89K	8.92M	8.92M	4.27M	7.12M	7.11M	7.26M	10.2M	15.64M
Basic Shares Outstanding	73.24K	952.89K	8.92M	8.92M	4.27M	7.12M	7.11M	7.26M	10.2M	15.64M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	491K	3.31M	10.93M	5.83M	35.94M	25.25M	15.88M	8.81M	7.92M	5.82M
Cash & Short-Term Investments	437K	2.71M	10.79M	5.24M	31.29M	24.65M	15.49M	8.28M	6.38M	5.47M
Cash Only	12.11M	2.71M	10.79M	5.24M	28.77M	19.65M	13.49M	2.52M	2.47M	3.11M
Short-Term Investments	-11.67M	0	0	0	2.52M	5M	2M	5.76M	3.92M	2.36M
Accounts Receivable	14K	15K	35K	65K	101K	0	174K	103K	1.49M	300K
Days Sales Outstanding	43.68	-	-	-	-	-	-	-	-	-
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	15K	400K	27K	437K	4.36M	424K	87K	3K	49K	49K
Total Non-Current Assets+	6.01M	53K	90K	259K	1.19M	1.03M	888K	723K	406K	212K
Property, Plant & Equipment	5.22M	53K	90K	259K	1.19M	1.03M	888K	723K	406K	212K
Fixed Asset Turnover	0.02x	-	-	-	-	-	-	-	-	-
Goodwill	184	0	0	0	0	0	0	0	0	0
Intangible Assets	45.82K	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	743K	0	0	0	0	0	0	0	0	0
Total Assets+	21.22M	3.37M	11.02M	6.09M	37.13M	26.28M	16.77M	9.54M	8.33M	6.03M
Asset Turnover	0.01x	-	-	-	-	-	-	-	-	-
Asset Growth %	-0.35%	-0.84%	2.27%	-0.45%	5.1%	-0.29%	-0.36%	-0.43%	-0.13%	-0.28%
Total Current Liabilities+	174K	783K	528K	4.76M	4.83M	1.34M	1.98M	2.07M	3.79M	2.46M
Accounts Payable	25K	512K	78K	630K	284K	275K	279K	116K	357K	165K
Days Payables Outstanding	536.76	18.69K	1.36K	4.26K	1.23K	-	-	-	1.23K	661.81
Short-Term Debt	0	0	0	0	0	0	0	283K	0	0
Deferred Revenue (Current)	16.83K	0	0	0	0	0	0	0	0	0
Other Current Liabilities	94.14K	0	386K	3.38M	3.73M	0	0	298K	804K	1.41M
Current Ratio	2.82x	4.23x	20.70x	1.23x	7.45x	18.78x	8.00x	4.26x	2.09x	2.37x
Quick Ratio	2.82x	4.23x	20.70x	1.23x	7.45x	18.78x	8.00x	4.26x	2.09x	2.37x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	419K	889K	528K	0	760K	626K	402K	179K	40K	41K
Long-Term Debt	419K	76K	0	0	0	0	0	0	0	0
Capital Lease Obligations	15.88K	0	0	0	760K	626K	402K	179K	40K	41K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	-15.88K	813K	528K	0	0	0	0	0	0	0
Total Liabilities	21.55M	1.67M	1.06M	4.76M	5.59M	1.97M	2.39M	2.25M	3.83M	2.5M
Total Debt+	454.91K	76K	0	0	903K	813K	680K	462K	231K	111K
Net Debt	-11.66M	-2.63M	-10.79M	-5.24M	-27.87M	-18.84M	-12.81M	-2.06M	-2.24M	-3M
Debt / Equity	-	0.04x	-	-	0.03x	0.03x	0.05x	0.06x	0.05x	0.03x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-72.52x	-28.85x	-22.13x	-	-70.29x	-113.61x	-	-	-	-
Total Equity+	-334K	1.7M	9.96M	1.33M	31.54M	24.31M	14.38M	7.29M	4.5M	3.53M
Equity Growth %	-1.06%	6.08%	4.88%	-0.87%	22.71%	-0.23%	-0.41%	-0.49%	-0.38%	-0.22%
Book Value per Share	-4.56	1.78	1.12	0.15	7.39	3.42	2.02	1.00	0.44	0.23
Total Shareholders' Equity	-334K	1.7M	9.96M	1.33M	31.54M	24.31M	14.38M	7.29M	4.5M	3.53M
Common Stock	1.11B	266K	27K	31K	72K	72K	72K	80K	118K	195K
Retained Earnings	-456.69M	-13.04M	-20.62M	-27.86M	-35.11M	-44.28M	-55.59M	-68.76M	-79.5M	-90.94M
Treasury Stock	0	0	0	-3.38M	-3.38M	0	0	0	0	0
Accumulated OCI	47.36K	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-765K	-786K	-4.86M	-5.31M	-6.45M	-7.25M	-9.35M	-11.55M	-8.53M	-8.83M
Operating CF Margin %	-6.54%	-	-	-	-	-	-	-	-	-
Operating CF Growth %	0.97%	-0.03%	-5.18%	-0.09%	-0.21%	-0.12%	-0.29%	-0.23%	0.26%	-0.03%
Net Income	-921K	-9.66M	-7.59M	-7.26M	-7.25M	-9.17M	-11.31M	-13.17M	-10.74M	-11.44M
Depreciation & Amortization	17K	10K	21K	54K	84K	68K	76K	102K	106K	91K
Stock-Based Compensation	0	676K	479K	1.4M	1.1M	1.94M	1.39M	1.75M	1.39M	1.35M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	7K	7.33M	2.32M	74K	-121K	-70K	0	-7K	718K	234K
Working Capital Changes	132K	862K	-83K	423K	-266K	-18K	497K	-228K	-11K	942K
Change in Receivables	66K	538K	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	292.19K	0	0	0	-140K	0	0	0	0	0
Cash from Investing+	-2K	-25K	-58K	-223K	-2.45M	-2.77M	3.2M	-3.84M	1.97M	1.54M
Capital Expenditures	-2K	-25K	-58K	-223K	-216K	-91K	-69K	-84K	-33K	-25K
CapEx % of Revenue	0.02%	-	-	-	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	259K	-200K	0	-3K	3K	0
Cash from Financing+	413K	3.08M	13.02M	-18K	36.77M	-3.38M	0	4.32M	6.56M	7.94M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-25.93M	2.33M	317K	-18K	0	0	0	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-767K	-811K	-4.91M	-5.53M	-6.67M	-7.34M	-9.42M	-11.63M	-8.57M	-8.85M
FCF Margin %	-6.56%	-	-	-	-	-	-	-	-	-
FCF Growth %	0.97%	-0.06%	-5.06%	-0.13%	-0.2%	-0.1%	-0.28%	-0.23%	0.26%	-0.03%
FCF per Share	-10.47	-0.85	-0.55	-0.62	-1.56	-1.03	-1.33	-1.60	-0.84	-0.57
FCF Conversion (FCF/Net Income)	0.02x	0.08x	0.64x	0.73x	0.89x	0.79x	0.83x	0.88x	0.79x	0.77x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-1315.39%	-1418.94%	-130.17%	-128.56%	-44.09%	-32.84%	-58.48%	-121.53%	-182.19%	-284.97%
Return on Invested Capital (ROIC)	-	-	-	-	-	-149.11%	-242.02%	-292.96%	-197.21%	-624.78%
Gross Margin	100%	-	-	-	-	-	-	-	-	-
Net Margin	-31123.93%	-	-	-	-	-	-	-	-	-
Debt / Equity	-	0.04x	-	-	0.03x	0.03x	0.05x	0.06x	0.05x	0.03x
Interest Coverage	-72.52x	-28.85x	-22.13x	-	-70.29x	-113.61x	-	-	-	-
FCF Conversion	0.02x	0.08x	0.64x	0.73x	0.89x	0.79x	0.83x	0.88x	0.79x	0.77x
Revenue Growth	-88.44%	-100%	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Microbot Medical Inc. (MBOT) grew revenue by 0.0% over the past year. Growth has been modest.

Microbot Medical Inc. (MBOT) reported a net loss of $13.1M for fiscal year 2024.

Dividend & Returns

Microbot Medical Inc. (MBOT) has a return on equity (ROE) of -285.0%. Negative ROE indicates the company is unprofitable.

Microbot Medical Inc. (MBOT) had negative free cash flow of $11.0M in fiscal year 2024, likely due to heavy capital investments.